Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 16Lymphoid 15Myeloid 10Gastrointestinal 5Classical hematology 5Plasma cell 4Dermatologic 4Sarcoma 3Other solid neoplasm 2Genitourinary 2Thoracic 1Other neoplasm 1NET 1Gynecologic 1Endocrine 1CNS 1

Conditions

Turcot syndrome 1Stomach Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Squamous Cell 1Microsatellite Instability 1Mesothelioma 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1

Interventions

Specimen Handling 9Magnetic Resonance Spectroscopy 9lutetium Lu 177 dotatate 6cabozantinib 6Nivolumab 5Ipilimumab 4fludarabine 3X-Rays 3Phantoms, Imaging 3Etoposide 3Cyclophosphamide 3CTLA-4 Antigen 3pembrolizumab 2olaparib 2aldesleukin 2Lutetium-177 2Lutetium 2Irinotecan 2Cisplatin 2Carboplatin 2trametinib 1tivozanib 1tipifarnib 1selpercatinib 1repotrectinib 1pazopanib 1gallium Ga 68 dotatate 1gallium 68 PSMA-11 1fluorodopa F 18 1fluorocholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
fludarabine phosphate × Endocrine × 30 days × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡